Selective Peroxisome Proliferator–Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?

PURPOSE OF REVIEW: Chronic kidney disease (CKD) poses a major global challenge, which is exacerbated by aging populations and the pandemic of type 2 diabetes mellitus. Much of the escalating burden of CKD is due to cardiovascular complications. Current treatment guidelines for dyslipidemia in CKD pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fruchart, Jean-Charles, Hermans, Michel P., Fruchart-Najib, Jamila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Nonstatin Drugs (M. Vrablik, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363727/
https://www.ncbi.nlm.nih.gov/pubmed/32671476
http://dx.doi.org/10.1007/s11883-020-00860-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363727/
https://www.ncbi.nlm.nih.gov/pubmed/32671476
http://dx.doi.org/10.1007/s11883-020-00860-w

Ejemplares similares